SlideShare a Scribd company logo
DRUGS USED IN PREGNANCY,
LABOUR AND PUERPERIUM
D.Padmapriya
Tutor
SAVEETHA CON
INTRODUCTION
• Drugs used in obstetrics have a huge impact
on the outcome of both mother and baby.
• Drugs used during first trimester can produce
congenital malformation and the period of
greatest risk is from the third to eleven weeks
of pregnancy
• During second and third trimester drugs can
affect the growth and functional development
of the fetus or they can have toxic effect on
fetus tissues.
DRUGS USED IN PREGNANCY
List of drugs used in pregnancy are:-
• Folic acid
• Iron
• Calcium
• Anti -hypertensive drugs
• Diuretics
FOLIC ACID
Preparation
• Injection- 10ml vial (5mg/ml with 1.5% benzyl
alchoal)
• Tablet- 0.4mg , o.8mg , 1mg
Action
Stimulates normal erythropoiesis and
nucleoprotein synthesis.
Indications
1. Megaloblastic or macrocytic anemia
during pregnancy to prevent fetal damage
2. Prevent fetal neural tube defect during
pregnancy
Contraindications
1. untreated vitamin B12 deficiency.
Adverse effects
1. Abdominal cramps
2. Diarrhoea
3. Rash
4. Irritability
5. nausea or bloating
Dosage and route of administration
0.4mg or 400mcg OD orally
0.4-0.8mg IM Or subcutaneously daily.
Nursing consideration
1. Patient with H/O fetal neural tube defect
in pregnancy should increase folic acid
intake 1 month before and 3 months after
conception.
2.Patient with intestinal malabsorption
may need parentral administration.
IRON (ferrous fumarate)
Preparation
Each 100mg provides 33mg of elemental iron.
Tablet- 90mg,200mg,300mg,325mg,350mg
Action
Provides elemental iron, an essential component
in the formation of haemoglobin.
Indications
1. Iron deficiency
2. As a supplement during pregnancy
Contraindications
1. Primary haemolytic anemia
2. Peptic ulcer disease
3. Ulcerative colitis
4. Repeated blood transfusions
Adverse effects
1. Metallic taste
2. Temporary stained teeth
3. Nausea or vomiting
4. GI irritation
5. Black stools
Dosage and routes of administration
 30mg OD orally
 Injection- 20mg elemental iron/ml in 5ml and 10ml single
dose vial (iron sucrose )
 Dose-15mg/kg body weight or max 1000mg in single Inj IM
Nursing considerations
1. Advised patient to avoid taking tablet with
milk or along with antacids.
2. Caution patient to crush tablet
3. Caution patient not to substitute one iron salt
for another because amount of elemental iron
may vary.
4. Advised patient to report for constipation or
change in stool colour
Calcium (calcium citrate)
Preparation
each tablet contains 211mg or 10.6meq of
elemental calcium
tablet- 250mg, 500mg
Action
Replaces calcium and maintain calcium level
Indication
supplement
containdications
1. Cancer patients with bone metastasis
2. Hypercalcemia
3.Hypophosphatemia
4.Renal calculi
Adverse effects
1. Headache
2. Irritability
3.Hypercalcemia
4.Chalky taste
5. Nausea or vomitings
Dosage and route of administration
Nursing considerations
1.Advise patient to take oral calcium 1 or
1.5 hours after meals if GI upset occurs
2. Monitor calcium level if the patient is
having mild renal impairment.
3. Advise patient to report for any kind of
abdominal pain, vomiting or nausea
occurs.
ANTIHYPERTENSIVE DRUGS
Here are the choice of drugs given during
pregnancy are:-
1. Alpha and Beta blockers- Labetalol
hydrochloride
2. calcium channel blockers-Nifedipine
3.alpha blockers-Methyldopa
4.vasodilators-Hydralazine hydrochloride
Anti hypertensive drugs contraindicated in
pregnancy
These drugs should be avoided because they
may can cause poor fetal renal function,
malformation or can cause IUGR
1.ACE inhibitors
2. Minoxidil
3. Sodium Nitoprusside
4. Diltiazem
5. Atenolol
6.Propranolol
Labetalol Hydrochloride
Preparation
Injection-5mg/ml in 2oml vial
Tablets- 100mg,2oomg ,300mg
Action
Reduced peripheral vascular resistance as a
result of alpha and beta blockade.
Indications
1.Hypertension
2.Hypertensive emergencies
Contraindications
1.Hypersensitive to drug or its component.
2.Bronchial asthma
3.Hepatic or heart failure
4.Prolonged hypotension
5.Severe bradycardia
Adverse effects
1. Dizziness
2. Fatigue
3. Nausea or vomiting
4. Headache
5. Vertigo
Dosage and route of administration
50mg or 100mg tablet OD orally
20mg/20ml Inj IV bolus wait for 10min if no response then
give 40mg slow bolus.
Nursing considerations
1. Advised patient to remain in supine position
for 3hrs after infusion.
2. Monitor BP frequently
3. In diabetic patient monitor glucose level
closely.
4. Advised patient that dizziness can be
minimized by rising slowly and avoiding sudden
position change
NIFEDIPINE
Preparations
Capsule-10mg,20mg
Tablet-20mg,30mg,60mg,90mg
Action
Thought to inhibit calcium ion reflex across
cardiac and smooth muscle cells, decreasing
contractility and oxygen demand and also dilates
arteries and arterioles.
Indications
1. Hypertension
2. Classic chronic stable angina pectoris.
Contraindications
1.Heart failure
2. Hypotension
3. Severe GI narrowing
Adverse effects
1. Dizziness
2. Syncope
3. Heart failure
4. Muscle cramps
5. Peripheral edema
Dosage and route of administrations
5-20mg OD orally.
Nursing considerations
1. Monitor BP & HR regularly
2. Advise patient to avoid taking this drug with
grapefruit juice.
3. Watch for symptoms for heart failure.
4. Advise patient if chest pain worsen
immediately report to doctor.
METHYLDOPA
Preparations
Tablet-250mg,500mg
Inj-50mg/ml
Action
Inhibit the central vasomotor centre, decreasing
sympathetic outflow to the heart, kidney and
peripheral vasculature.
Indications
1. Hypertension
2. Hypertensive crisis
Contraindications
1. Hepatic disease or liver cirrhosis
2. Lactating mother
Adverse effects
1. Decrease mental acuity
2. Sedation
3. Headache or depression
4. Bradycardia
5. Hepatic necrosis
Dosage and routes of administration
 250mg BD or TDS max 2g daily titrated by BP
Nursing considerations
1. Monitor BP regularly.
2. Monitor patient coomb’s test result.
3. Report for involuntary movements.
4.Tell patient to check weight daily and notify if he gains
2 or more pounds in a week
Hydralazine Hydrochloride
Preparation
 Inj-20mg/ml in 1ml vial
 Tablet-10mg,25g,50mg,100mg
Action
Direct acting peripheral vasodilator that relexes arteriolar
smooth muscle.
Indications
1. Hypertension
2. Severe essential hypertension
contraindications
1. Coronary artery disease
2. Rheumatic heart disease
3. Stroke
4. Severe renal impairment
Adverse effects
1. Neutropenia
2. Leukopenia
3.Thrombocytopenia
4. Orthostatic hypotension
Dosage and route of administration
 25mg tablet BD and if necessary may increase to
50mg BD
 5mg diluted in 10ml of NS slow IV at 15-20minutes
interval.
Nursing considerations
1. Monitor patient BP, pulse rate, body weight frequently.
2. Monitor patient for muscle and joint pain, fever or
throat pain.
3. Advised patient to take drug after food to increase
absorption
DIURETICS
Diuretics are used in the following conditions
during pregnancy:
1. PIH with massive edema
2. Eclampsia with pulmonary edema
3. Severe anemia in pregnancy with heart failure
4. Prior to blood transfusion in severe anemia
5. As an adjunct to certain antihypertensive
drugs.
FUROSEMIDE (LASIX)
Preparation
 Inj-10mg/ml
 Tablets-20mg,40mg,80mg,500mg
Action
Inhibits sodium and chloride reabsorption at proximal
and distal tubules and loop of Henle.
Indications
1. Acute pulmonary edema
2. Edema
3. Hypertension
Contraindications
1. Anuria
2. Hepatic cirrhosis
3. Allergic to sulfonamides
Adverse effects
1. Maternal: Weakness, fatigue, muscle cramps, hypokalemia
2. Fetal: May occur due to decreased leading to fetal compromise,
hyponatremia.
Dosage and routes of administration
 40 mg tablet, daily following breakfast.
 In acute conditions, the drug is administered parenterally in
doses of 40-120 mg daily.
Nursing considerations
1. Monitor weight, BP and pulse rate routinely
for long term use.
2. Monitor patient I/O chart.
3. Watch the signs for hypokalemia such as
muscle weakness and cramps.
4. Monitor uric acid if patient is having gout.
5. Advise the patient to take drug in the morning
after food.
6. Advised patient to avoid direct sunlight to
prevent photosensitivity reactions.
TOCOLYTIC AGENTS
These drugs can inhibit uterine contractions &
used to prolonged the pregnancy. In women
who develop premature uterine contractions, in
addition to putting them to absolute bed rest &
sedating, Tocolytic drugs are administered in
an attempt to inhibit uterine contraction.
Here are the drugs used are:-
1. Isoxsuprine Hydrochloride
2. Ritrodrine hydrochloride
Isoxsuprine hydrochloride
(Duvadilan)
Preparation
 Tablet -10mg
 Inj-10mg/ml
Action
Acts directly on vascular smooth muscle, causes cardiac
stimulation & uterine relaxation And thus causing relaxing the veins
and arteries and making them wider to increase the blood flow to
certain parts of the body.
Indication
1. Prevent Preterm labour
2. Inhibit uterine contractions.
Contraindications
1. Hypersensitivity
2. Postpartum
Adverse effects
1. Hypotension
2. Tachycardia
3. Nausea or vomiting
4. Pulmonary edema
5. Cardiac arrhythmias
6. Hyperglycemia or hypokalemia
Dosage & routes of administration
 Initial: IV drip 100 mg in 5% dextrose @Rate0.2ug/minute.
 To continue at least 2 hours after the contractions cease
 Maintenance: IM 10mg 6 hourly for 24 hrs or tab 10mg 6-
8hrly.
Nursing considerations
1. Assess patient BP, pulse during treatment
2.Take BP lying & standing as orthostatic hypotension is
common
3. Monitor for Intensity & length of uterine contractions and
FHS.
4. Advise patient to make position changes slowly as
fainting may occur.
Ritodrine hydrochloride (yutopar)
Preparation
 Inj-5ml amp-10mg/ml=50mg per amp.
 Tablet-10mg
Action
Acts directly on vascular smooth muscle, causes cardiac stimulation &
uterine relaxant.
Indications
Prevent preterm labour
Contraindications
1. Hypersensitivity
2. Eclampsia
3. Hypertension
4. Dysrhythmias
Adverse effects
1.Hyperglycemia
2. Headache
3. Restlessness or sweating
4. Chills and drowsiness
5. Nausea or vomiting
6. Altered maternal & fetal heart tone & palpitations.
Dosage and routes of administration
 Initial: IV drip 100 mg in 5% dextrose @ 0.1 mg/minute gradually
increased by 0.05mg/min ,To continue for at least 2 hrs after
contractions cease.
 Maintenance -Tab 10mg 6-8 hourly PO 10 mg given half hour
before termination of iv, then 10 mg q2 hr x 24 hrs, then 10-20
mg q4th, not to exceed 120 mg/day
Nursing considerations
1. Assess Maternal & fetal heart tones during infusion
and also Intensity & length of uterine contractions
2. Monitor Fluid intake to prevent fluid overload,
discontinue if this occurs.
3. Administer only clear solutions after dilution 150 mg
in 500 ml D5W or NS, give at 0.3 mg/ml By Using
infusion pumps/monitor carefully
4. Positioning of patient in left lateral recumbent
position to decrease hypotension & increase renal
blood flow.
5. Advise patient to remain in bed during infusion.
DRUGS USED IN LABOR
Here are the drugs used in labor are:-
1.Oxytocics
2. Analgesics
3. Anticonvulsant
4. Anticoagulant
OXYTOCICS
Oxytocics are the drugs that have the power to
excite contractions of the uterine muscles.
Among a large number of drugs belonging to
this group the ones that are important and
extensively used are :-
1. Oxytocin
2. Ergot derivatives
3. Prostaglandins
OXYTOCIN
Oxytocin is an octapeptide synthesized in the hypothalamus and
stored in the posterior pituitary.
Preparations
Synthetic oxytocin available for parenteral use includes:-
• Syntocinon : 5units/ml in ampoules of 1 ml
• Pitocin 10 units/ml in ampoule of 0.5 ml
• Syntometrine : A combination of syntocinon on 5 units &
ergometrine 0.5mg
• Oxytocin nasal solution 40 unit/ml
Actions
Acts directly on myofibrils producing uterine contractions &
stimulates milk ejection by the breasts
Indications
Pregnancy
1.To induce abortion, labour
2.To expedite expulsion of hydatidiform mole
3. For oxytocin challenge test
4.To stop bleeding following evacuation.
Labour
1.To augment labour, in uterine inertia
2. to prevent & treat postpartum hemorrhage
Postpartum
1.To initiate milk let-down in breast engorgement.
Contraindications
In late pregnancy
1. Grand multipara
2. Contracted pelvis
3. History of LSCS or hysterectomy
4. Malpresentation
During labour
1. All contraindications mentioned in pregnancy
2. Obstructed labour
3. Incoordinate uterine action
Anytime
1. Hypovolemic state, cardiac disease
Adverse effects
1. Hypertonic uterine activity
2. Fetal distress & fetal death
3. Uterine rupture
4. Hypotension
5. Neonatal jaundice
6. Water retention & water intoxication
Dosage & routes of administration
 Controlled IV infusion ( 10 units of oxytocin in 1 L of
RL/5% Dextrose in water)
 Nasal spray for milk let- down
Nursing considerations
1. Assess Patient I/O Ratio, Uterine contraction,
BP, pulse & respiration
2. Administer By IV infusion After having crash
cart available in the ward
3. Evaluate patient Length & duration of
contractions and Notify physician of
contractions lasting over one minute or absence
of contractions.
ERGOT DERIVATIVES
Ergot alkaloids are either natural or semi
synthetic
Preparations
Ergometrine- 0.25mg/ 0.5mg
ampoules & 0.5-1mg tablets
Methergine - 0.2 mg ampoules & 0.5-1mg tablets
Syntometrine Ergometrine - 0.5 mg+ syntocinon
5.0 units ampoules.
NOTE
 Ergometrine & Methergine can be used parenterally or
orally. As the drug produces titanic uterine
contractions, it should only be used after delivery of
the anterior shoulder or following delivery of baby.
 It should not be used in induction of labor or abortion.
 Syntometrine should always be administered IM
Mode of Action
Ergometrine acts directly on the myometrium. It
stimulates uterine contractions & decreases bleeding.
Indications
Therapeutic
1.To stop the atonic uterine bleeding following delivery,
abortion/ expulsion of hydatidiform mole
Prophylactic
1. As a prophylaxis against excessive hemorrhage , it
may be administered after the delivery of the anterior
shoulder with crowing / following delivery of baby.
Contraindications
1. Suspected plural pregnancy
2. Organic cardiac disease
3. Severe Pre-eclampsia & Eclampsia
Adverse effects
1. Rise of BP due to vasoconstriction action
2. Prolonged use in puerperium may interfere by
decrease concentration of prolactin & gangrene of toes
due to vasoconstriction.
Dosage and routes of administration
 For active management of 3rd stage of labour -
0.2mg(iamp) to be given IM.
 For control of atonic PPH -1amp slowly over 60
seconds, may be repeated after 2hrs.
 For excessive lochia and subinvolution-1
Tablet(0.125mg)TDS for 3 days.
Nursing considerations
1. Assess patient BP, pulse, respiration, signs
of hemorrhage
2. Administer Orally/IM deep, have emergency
cart readily available
3. Evaluate for decrease blood loss
4. Advised patient to report for increased blood
loss, abdominal cramps, headache, sweating,
nausea, vomiting/ dyspnea
PROSTAGLANDINS
Prostaglandins are synthesized from one of the essential
fatty acids, archidonic acid, which is widely distributed
throughout the body. In the female, these are identified in
the menstrual fluid, endometrium, decidua & amniotic
membrane.
Preparations
Tablet- 0.5mg
1. PG E2 – Prostin E2 ( Dinoprostone)
Gel-0.5mg E2 in 2.5ml gel-comes in pre loaded syringe.
2. PG F2 alpha- Prostin F2 alpha ( Dinoprostodine)
Inj- 125 and 250mcg
3. PGE1 – Misoprostol
Tablet-100mcg,200mcg,600mcg
Action
Both PGE2 & PGF2 alpha have an oxytocic effect on the
pregnant uterus. They also sensitize the myometrium to
oxytocin. PGF2 alpha acts predominantly on the
myometrium, while PGE2 acts mainly on the cervix.
Indications
1. For induction of abortion during 2nd trimester & expulsion
of hydatidiform mole
2. For induction of labor in IUD of fetus
3. In augmentation/ acceleration of labor
4.To stop bleeding from the open uterine sinuses as in
refractory cases of atonic PPH
5. Cervical ripening
Contraindications
1. Hypersensitivity
2. Uterine fibroids
3. Cervical stenosis
4. PID
Side effects
1. Headache
2. Dizziness
3. Hypertension
4. leg cramps
5. Joint swelling
Dosage & routes of administration
 Tablets: containing o.5 mg prostin E2
 Vaginal suppository: containing 20 mg PGE2 or 50 mg PGF2
alpha
 Vaginal pessary: 3mg PGE2
 Injectable ampoules/vials of prostinE2
 1 mg/ml prostin F2 alpha
 5mg/ml Misoprostol 50mg given 4 hourly by oral, vaginal/ rectal
route for induction of labour
Nursing considerations
1. Assess patient RR, rhythm & depth, vaginal discharge,
itching/ irritation
2. Administer Antiemetic/ antidiarrheal preparations prior
to giving this drug, high in vagina, after warming the
suppository by running warm water over package
3. Evaluate patient for length & duration of contractions,
notify physician of contractions lasting over 1 minute or
absence of contractions, fever & chills
4. Advised patient to remain supine for 10-15 minutes
after vaginal insertion.
ANTICONVULSANTS
MAGNESIUM SULPHATE
Preparation
 Inj- 1amp=2ml contains 1gm Mgso4.
 Tablet-64mg
Action
Decreased acetylcholine in motor nerve terminals,
which is responsible for anticonvulsant properties,
thereby reduces neuromuscular irritability. It also
decreases intracranial edema & helps in diuresis. Its
peripheral vasodilatation effect improves the uterine
blood supply. Has depressant action on the uterine
muscles & CNS
Indications
1. It is a valuable drug lowering seizure threshold in women with
pregnancy- induced hypertension.
2. Used in preterm labor to decrease uterine activity.
Contraindications
1. Heart block
2. Impaired renal function
3. Pregnant women actively progressing labor.
Adverse effects
• Maternal
1. Severe CNS depression
2. Evidence of muscular paresis
• Fetal
1.Tachycardia
2. Hypoglycemia
Dosage & routes of administration
1. For control of seizures, 20 ml of 20% solution IV slowly
in 3-4 mins, to be followed immediately by 10ml of 50%
solution IM & continued 4 hourly till 24 hours
postpartum.
Repeat injections are given only if knee jerks are present,
urine output exceeds 100 ml in 4 hours & respiration are
more than 10/ minute. The therapeutic level of serum
magnesium is 4-7 mEq/L
2. 4gm IV slowly over 10 min, followed by 2 gm/hr and
then 1gm/ hr in drip of 5% dextrose for tocolytic effect
Nursing considerations
1. Assess patients Vital signs 15 min after IV dose, do not
exceed 150 mg/min
2. Monitor magnesium level If using during labour, time of
contractions, determine intensity
3. Urine output should remain 30 ml/hr or more if less
notify physician
4. Examine patient Reflexes-knee jerk, patellar reflex.
5. Administer Only after calcium gluconate is available for
treating magnesium toxicity
6. Using infusion pump/monitor carefully, IV at less than
150mg/min ,circulatory collapse may occur
7. Provide Seizure precautions: place client in single
room with decreased stimuli, padded side rails
8. Positioning of client in left lateral recumbent position
to decrease hypotension & increased renal blood flow
9. Evaluate patient Mental status , sensorium, memory ,
Respiratory status & Reflexes.
10. Discontinue infusion if respirations are below 12/min,
reflexes severely hypotonic, urine output below 30ml/hr
or in the event of mental confusion/ lethargy/ fetal
distress.
ANALGESICS
valethamate bromide (epidosin)
Cervical spasmolytic
Preparation
Inj-1amp-8mg/ml
Action
It is both central and peripheral antimuscarininc agent, which is a
competitive inhibitor of acetylcholine at the muscarinic receptor.
Indication
1. Cervical dilatation in the first stage of labor.
2. Symptomatic relief of GI tract and ureteric colic.
Contraindications
1. Paralytic ileus
2. Myasthemia Gravis
3. Hypertension
4. Ulcerative colitis
5. Closed angle glaucoma
6. CVS disorders
Adverse effects
1. Dryness of mouth
2. Thirst
3. Dilatation of pupil
4. Palpitations
5. Giddiness
Dosage and routes of administration
Inj-8mg deep IM. It may be repeated after 4 hours
if necessary.
Nursing considerations
1. Advise patient to report for any blurred vision,
giddiness ,dry mouth immediately.
2. Advise patient to get up from the bed carefully
and slowly.
Tramadol hydrochloride
Preparation
 Inj-1amp=50mg
 Tablet-50mg,100mg,200mg
Action
Bind to opioid receptor and inhibit reuptake of
norepinephrine and serotonin
Indications
1. Moderate to moderately severe pain
2. Safe given during labor as it does not cause depression
to fetal respiratory centre and hence safe for baby.
Contraindications
1. Breast feeding mothers
2. Hypersensitiviy
3. Hepatic impairment
4. Increased ICP
Adverse effects
1. Dizziness
2. Headache
3. Malaise
4. Hypertonia
5. Nausea or vomiting
Dosage and routes of administration
50 to 100mg IM 6hrly or as required.
Nursing considerations
1. Monitor patient CV and respiratory status.
2. Monitor patient at risk for seizure.
3. Monitor patient bowel and bladder function.
COAGULANT
Vitamin K(phytonadione
At birth, the newborn does not have bacteria in
the colon that necessary for synthesizing fat
soluble vitamin k. Therefore newborns have
decreased level of Prothrombin during the first 5
to 8 days of life.
Preparation
INJ- 2ml vial=2mg/ml
Action
It promotes the hepatic formation of the clotting factors
II,VII,IX and X.
Indications
1. It is used to treat or prevent certain bleeding problems.
2. It helps liver to produce blood clotting factors
Contraindications
Hypersensitivity
Adverse effects
1. Pain and edema may occur at injection site.
2. Allergic reaction such as rash and urticarial may
occur.
3. Hyperbilirubinemia
Dosage and routes of administration
0.5mg IM within 1 hour of birth.
Nursing considerations
1. Document the giving of the medication to
newborn to prevent an accidental doubling.
2. Observe for bleeding usually occurs on 2nd
and 3rd day.
3. Observe for jaundice
4. Observe for local inflammation.
DRUGS GIVEN DURING PUERPERIUM
Here are the drugs given during puperium
are:-
1.Iron
2.Folic acid
3.Calcium
4.Acetaminophen(paracetamol)
5.Lactation suppressant (in case of stillbirth,
neonatal death, breast abscess or severe
psychiatric illness.
Acetaminophen (paracetamol)
Preparation
 Tablet-80mg,160mg,500mg
 Suppository-80mg,120mg
 Oral solution-16m/ml,80mg/ml
Action
Produce analgesia by inhibiting prostaglandins and other
substances that sensitizes pain receptors.
Indications
1. Mild to moderate pain
2. Fever
Contraindications
1. Liver disease
2. Hypersensitivity
Adverse effects
1. Neutropenia
2. Hemolytic anemia
3. Hypoglycemia
4. Urticaria
Dosage and routes of administration
500mg tablet thrice a day for 5 days
Nursing considerations
1. Advise the patient to not to exceed the
prescribed dose.
2. Advise the patient hat drug is only for short
term use and avoid taking OTC drugs without
prescription.
3. Advise patient to take tablet after meal to
prevent GI symptoms.
Lactation suppressants
(Bromocriptine mesylate)
Preparation
 Tablet-0.8mg,2.5mg
Action
It blocks the release of a prolactin from the pituitary
gland.
Indications
1. Suppression of lactation
2. Pregnancy with prolactinoma
3. Infertility
4.Amenorrhoea
Adverse effects
1. Dizziness or lightheadedness especially when getting
up from lying position.
2. Confusion
3. Hallucinations
4. Hypertension
5. Seizures
6. Myocardial infarction
Dosage and routes of administration
 2.5mg tablet orally once in a day.
Nursing considerations
1. Monitor patient for adverse reactions
2. Drug may lead to early post partum
conception .after menses resumes, test
for pregnancy every 4 weeks or as soon
as period is missed
3. Assess orthostatic vital signs before
initiation of the therapy.
4. Instruct the patient to take drug with
meal.
EFFECTS OF MATERNAL MEDICATIONS
ON FETUS & BREAST FEEDING INFANTS
1. During early embryogenesis, the drugs taken by the
mother reach the conceptus through the tubal/ uterine
secretions by diffusion.
2. The harmful effect on the blastocyst is usually death, in
case of survival there is chance of congenital anomalies
3. From 2nd-12th week (period of organogenesis) drugs can
cause serious damages
4. Gross congenital malformations & even death of the
fetus may result, depending on route, length of time & dose
of exposure
5. From 2nd trimester transfer of drugs takes place
through the utero-placental circulation due to lowered
serum albumin concentration which results from
haemodilution
6. As the albumin binding capacity of the drugs is
decreased more free drug is available for placental
transfer
7.The metabolism of the drug may be hampered by the
increase in plasma steroids, increased utero-placental
blood flow, increased placental surface area & decreased
thickness of placental membrane are the additional
cause for increased drug transfer
8. Fetotoxic/ teratogenic drugs are prescribed only when
the benefits out weigh the potential risks. Prior
councelling is mandatory & minimum therapeutic dosage
is used for shortest possible duration
Maternal medications with established
teratogenic properties & their effects
1.Cytotoxic drugs: multiple fetal malformations &
abortion
2.Androgenic steroids, hydroxy progesterone:
masculinization of the female offspring
3.Lithium: increased congenital malformations when
used in the 1st trimester, neonatal goitre, hypotonia
& cynosis
4.Diethyl stillbestrol: vaginal stenosis, cervical
hoods & uterine hypoplasia in female fetuses.
Maternal drug intake & breastfeeding
Maternal drug intake of nursing mothers have adverse
effects on lactation & also on the baby as it may be
present on the breast milk
• Transfer of drugs through breast milk depends on the
following factors:
• Chemical properties
• Molecular weight
• Degree of protein binding
• Ionic dissociation
• Lipid solubility
• Tissue pH
• Drug concentration
• Exposure time
Drugs identified as having effects on
lactation & the neonates are listed below:
• Bromides: rash, drowsiness, poor feeding
• Iodides: neonatal hypothyroidism
• Chloramphenicol: bone marrow toxicity
• Oral pill: suppression of lactation
• Bromocriptine: suppression of lactation
• Ergot: suppression of lactation
• Metronidazol: anorexia, blood dyscrasias,
weakness, neurotoxic disorders
• Anticoagulants: hemorrhagic tendency
• Isoniazid: anti-DNA activity &
hepatotoxicity
• Antithyroid drugs & radioactive iodine:
hypothyroidism & goiter
• Diazepam, opiates, phenobarbitone:
sedation effect with poor sucking reflex.
CONCLUSION
• No drug should be administered to a woman during
pregnancy, labor and birth, unless the woman is fully
informed of the known risks and the relevant areas of
uncertainty regarding the effects of the drug on the
physiologic and neurologic development of the woman
or her baby
• The drugs that are used daily in obstetric can have a
huge impact on the outcome of both mother and child.
• Therefore, obstetric providers need to have a very clear
understanding of the mechanism of action, doses and
side-effects of the most commonly used drugs.
BIBLIOGRAPHY
• 1. Annamma Jacob “ A Comprehensive Textbook of
Midwifery & Gynecological Nursing” 3rd edition. Jaypee
Brothers Medical Publishers (P) Ltd page no. 604-619
• 2. D.C.Dutta’s “Textbooks of Obstetrics” 7th edition. New
Central Book Agency (P) Ltd page no.666.
• 3. A.K Debdas “Drug handbook in Obstetrics”,3rd
edition.Jaypee brothers and medical publishers private
limited, New Delhi.
• 4. wolter Kluwer “Drug handbook”32 edition.lippincot
William &Wilkinson publisher ,London.
• 5.www.medicine.tcd.ie/pharmacology_therapeutics/....Obs&G
yn.pdf
• 6.www.elmmb.nhs.uk/formularies/joint-medicines-
Drugs used in pregnancy, labour and puerperium

More Related Content

What's hot

Fourth stage of labor
Fourth stage of labor Fourth stage of labor
Fourth stage of labor
DR MUKESH SAH
 
Minor disorders of puerperium
Minor disorders of puerperiumMinor disorders of puerperium
Minor disorders of puerperium
Stephanopoulos Osei
 
PREMATURE LABOR
PREMATURE LABORPREMATURE LABOR
PREMATURE LABOR
Snehlata Parashar
 
Management of third stage of labour
Management of third stage of labourManagement of third stage of labour
Management of third stage of labour
P V GREESHMA
 
Legal and ethical aspects in obg 0109
Legal and ethical aspects in obg 0109Legal and ethical aspects in obg 0109
Legal and ethical aspects in obg 0109
Krupa Meet Patel
 
Antihypertensive and Anticonvulsant drugs in OBG
Antihypertensive and Anticonvulsant drugs in OBGAntihypertensive and Anticonvulsant drugs in OBG
Antihypertensive and Anticonvulsant drugs in OBG
Santosh Kumari
 
1st stage managment
1st stage managment1st stage managment
1st stage managment
Nirsuba Gurung
 
3rd stage OF LABOUR
3rd stage OF LABOUR 3rd stage OF LABOUR
3rd stage OF LABOUR
Amandeep Jhinjar
 
Breastcare
BreastcareBreastcare
Breastcare
Nikita Sharma
 
Minor disorders of pregnancy and their management
Minor disorders of pregnancy and their managementMinor disorders of pregnancy and their management
Minor disorders of pregnancy and their management
Sharon Treesa Antony
 
Ethical and legal issues in midwifery and obstetrics nursing
Ethical and legal issues in midwifery and obstetrics nursingEthical and legal issues in midwifery and obstetrics nursing
Ethical and legal issues in midwifery and obstetrics nursing
Abhilasha verma
 
MINOR OF DISORDER OF NEWBORN.pptx
MINOR OF DISORDER OF NEWBORN.pptxMINOR OF DISORDER OF NEWBORN.pptx
MINOR OF DISORDER OF NEWBORN.pptx
Snehlata Parashar
 
Subinvolution
SubinvolutionSubinvolution
Lactation management
Lactation managementLactation management
Lactation management
punisahoo
 
Gestational Diabetes Mellitus and Nursing Management
Gestational Diabetes Mellitus and Nursing ManagementGestational Diabetes Mellitus and Nursing Management
Gestational Diabetes Mellitus and Nursing Management
Birat Medical College, Kathmandu University, Nepal
 
Management of ailment during puerperium
Management of ailment during puerperiumManagement of ailment during puerperium
Management of ailment during puerperium
PRANATI PATRA
 
NURSING MANAGEMENT OF SECOND STAGE OF LABOUR
NURSING MANAGEMENT OF SECOND STAGE OF LABOURNURSING MANAGEMENT OF SECOND STAGE OF LABOUR
NURSING MANAGEMENT OF SECOND STAGE OF LABOUR
Drisya Nidhin
 
Second stage of labor
Second stage of laborSecond stage of labor
Second stage of labor
DR MUKESH SAH
 
Partograph
Partograph Partograph
Partograph
Shagufa Jamal
 
Preparation for delivery of mother, baby and midwife and equipments
Preparation for delivery of mother, baby and midwife and equipmentsPreparation for delivery of mother, baby and midwife and equipments
Preparation for delivery of mother, baby and midwife and equipments
DR MUKESH SAH
 

What's hot (20)

Fourth stage of labor
Fourth stage of labor Fourth stage of labor
Fourth stage of labor
 
Minor disorders of puerperium
Minor disorders of puerperiumMinor disorders of puerperium
Minor disorders of puerperium
 
PREMATURE LABOR
PREMATURE LABORPREMATURE LABOR
PREMATURE LABOR
 
Management of third stage of labour
Management of third stage of labourManagement of third stage of labour
Management of third stage of labour
 
Legal and ethical aspects in obg 0109
Legal and ethical aspects in obg 0109Legal and ethical aspects in obg 0109
Legal and ethical aspects in obg 0109
 
Antihypertensive and Anticonvulsant drugs in OBG
Antihypertensive and Anticonvulsant drugs in OBGAntihypertensive and Anticonvulsant drugs in OBG
Antihypertensive and Anticonvulsant drugs in OBG
 
1st stage managment
1st stage managment1st stage managment
1st stage managment
 
3rd stage OF LABOUR
3rd stage OF LABOUR 3rd stage OF LABOUR
3rd stage OF LABOUR
 
Breastcare
BreastcareBreastcare
Breastcare
 
Minor disorders of pregnancy and their management
Minor disorders of pregnancy and their managementMinor disorders of pregnancy and their management
Minor disorders of pregnancy and their management
 
Ethical and legal issues in midwifery and obstetrics nursing
Ethical and legal issues in midwifery and obstetrics nursingEthical and legal issues in midwifery and obstetrics nursing
Ethical and legal issues in midwifery and obstetrics nursing
 
MINOR OF DISORDER OF NEWBORN.pptx
MINOR OF DISORDER OF NEWBORN.pptxMINOR OF DISORDER OF NEWBORN.pptx
MINOR OF DISORDER OF NEWBORN.pptx
 
Subinvolution
SubinvolutionSubinvolution
Subinvolution
 
Lactation management
Lactation managementLactation management
Lactation management
 
Gestational Diabetes Mellitus and Nursing Management
Gestational Diabetes Mellitus and Nursing ManagementGestational Diabetes Mellitus and Nursing Management
Gestational Diabetes Mellitus and Nursing Management
 
Management of ailment during puerperium
Management of ailment during puerperiumManagement of ailment during puerperium
Management of ailment during puerperium
 
NURSING MANAGEMENT OF SECOND STAGE OF LABOUR
NURSING MANAGEMENT OF SECOND STAGE OF LABOURNURSING MANAGEMENT OF SECOND STAGE OF LABOUR
NURSING MANAGEMENT OF SECOND STAGE OF LABOUR
 
Second stage of labor
Second stage of laborSecond stage of labor
Second stage of labor
 
Partograph
Partograph Partograph
Partograph
 
Preparation for delivery of mother, baby and midwife and equipments
Preparation for delivery of mother, baby and midwife and equipmentsPreparation for delivery of mother, baby and midwife and equipments
Preparation for delivery of mother, baby and midwife and equipments
 

Similar to Drugs used in pregnancy, labour and puerperium

medicine foer midwife.pdf college of midwifery
medicine foer midwife.pdf college of midwiferymedicine foer midwife.pdf college of midwifery
medicine foer midwife.pdf college of midwifery
abdinuh1997
 
drug book file on obs. and gynae clinical pstings
drug book file on obs. and gynae clinical pstingsdrug book file on obs. and gynae clinical pstings
drug book file on obs. and gynae clinical pstings
Karishma7720
 
Drugs used in hormonal disorders & supplementation etc
Drugs used in hormonal disorders & supplementation etcDrugs used in hormonal disorders & supplementation etc
Drugs used in hormonal disorders & supplementation etc
Mr. Dipti sorte
 
Drugs used in hormonal disorders supplementation etc.
Drugs used in hormonal disorders supplementation etc.Drugs used in hormonal disorders supplementation etc.
Drugs used in hormonal disorders supplementation etc.
Abhay Rajpoot
 
drugs used in hormonal disorders supplementation.pptx
drugs used in hormonal disorders supplementation.pptxdrugs used in hormonal disorders supplementation.pptx
drugs used in hormonal disorders supplementation.pptx
Jayesh Patidar
 
NurseReview.Org Pharmacology Endocrine Drugs
NurseReview.Org Pharmacology  Endocrine DrugsNurseReview.Org Pharmacology  Endocrine Drugs
NurseReview.Org Pharmacology Endocrine Drugs
Nurse ReviewDotOrg
 
Antihypertensive and diuretics action& side effects.pptx
Antihypertensive and diuretics action& side effects.pptxAntihypertensive and diuretics action& side effects.pptx
Antihypertensive and diuretics action& side effects.pptx
shivaguru23
 
Pharmaco therapeutics in obstetrics
Pharmaco therapeutics in obstetricsPharmaco therapeutics in obstetrics
Pharmaco therapeutics in obstetrics
123shital
 
Pharmacology Endocrine Drugs
Pharmacology   Endocrine DrugsPharmacology   Endocrine Drugs
Pharmacology Endocrine Drugs
pinoy nurze
 
Oral hypoglycemic agents
Oral hypoglycemic agentsOral hypoglycemic agents
Oral hypoglycemic agents
sabahat96
 
Dsme taking medication powerpoint
Dsme taking medication powerpointDsme taking medication powerpoint
Dsme taking medication powerpoint
Stacy McDaniel
 
Treatment of type ii diabetes by Husna Saqlain
Treatment of type ii diabetes by Husna SaqlainTreatment of type ii diabetes by Husna Saqlain
Treatment of type ii diabetes by Husna Saqlain
PARUL UNIVERSITY
 
OHA.pptx
OHA.pptxOHA.pptx
OHA.pptx
KIMS
 
Case study -pneumonia
Case study -pneumoniaCase study -pneumonia
Case study -pneumonia
Riddhi Pawaskar
 
Hypertension disorders during pregnancy
Hypertension disorders during pregnancyHypertension disorders during pregnancy
Hypertension disorders during pregnancy
Vasundhara Hospital
 
2. Gynacological complications (3).pptx
2. Gynacological complications (3).pptx2. Gynacological complications (3).pptx
2. Gynacological complications (3).pptx
JibrilAliSe
 
DRUG-STUDY-for-Case-presentation-finale.docx
DRUG-STUDY-for-Case-presentation-finale.docxDRUG-STUDY-for-Case-presentation-finale.docx
DRUG-STUDY-for-Case-presentation-finale.docx
NardelizaLumauig1
 
Drug Used in Obstetric
Drug Used in ObstetricDrug Used in Obstetric

Similar to Drugs used in pregnancy, labour and puerperium (20)

medicine foer midwife.pdf college of midwifery
medicine foer midwife.pdf college of midwiferymedicine foer midwife.pdf college of midwifery
medicine foer midwife.pdf college of midwifery
 
drug book file on obs. and gynae clinical pstings
drug book file on obs. and gynae clinical pstingsdrug book file on obs. and gynae clinical pstings
drug book file on obs. and gynae clinical pstings
 
Pharmacotherapeutics in obstetrics
Pharmacotherapeutics in obstetricsPharmacotherapeutics in obstetrics
Pharmacotherapeutics in obstetrics
 
Drugs used in hormonal disorders & supplementation etc
Drugs used in hormonal disorders & supplementation etcDrugs used in hormonal disorders & supplementation etc
Drugs used in hormonal disorders & supplementation etc
 
Drugs used in hormonal disorders supplementation etc.
Drugs used in hormonal disorders supplementation etc.Drugs used in hormonal disorders supplementation etc.
Drugs used in hormonal disorders supplementation etc.
 
drugs used in hormonal disorders supplementation.pptx
drugs used in hormonal disorders supplementation.pptxdrugs used in hormonal disorders supplementation.pptx
drugs used in hormonal disorders supplementation.pptx
 
NurseReview.Org Pharmacology Endocrine Drugs
NurseReview.Org Pharmacology  Endocrine DrugsNurseReview.Org Pharmacology  Endocrine Drugs
NurseReview.Org Pharmacology Endocrine Drugs
 
Antihypertensive and diuretics action& side effects.pptx
Antihypertensive and diuretics action& side effects.pptxAntihypertensive and diuretics action& side effects.pptx
Antihypertensive and diuretics action& side effects.pptx
 
Pharmaco therapeutics in obstetrics
Pharmaco therapeutics in obstetricsPharmaco therapeutics in obstetrics
Pharmaco therapeutics in obstetrics
 
Pharmacology Endocrine Drugs
Pharmacology   Endocrine DrugsPharmacology   Endocrine Drugs
Pharmacology Endocrine Drugs
 
Oral hypoglycemic agents
Oral hypoglycemic agentsOral hypoglycemic agents
Oral hypoglycemic agents
 
Dsme taking medication powerpoint
Dsme taking medication powerpointDsme taking medication powerpoint
Dsme taking medication powerpoint
 
Treatment of type ii diabetes by Husna Saqlain
Treatment of type ii diabetes by Husna SaqlainTreatment of type ii diabetes by Husna Saqlain
Treatment of type ii diabetes by Husna Saqlain
 
OHA.pptx
OHA.pptxOHA.pptx
OHA.pptx
 
Case study -pneumonia
Case study -pneumoniaCase study -pneumonia
Case study -pneumonia
 
Hypertension disorders during pregnancy
Hypertension disorders during pregnancyHypertension disorders during pregnancy
Hypertension disorders during pregnancy
 
2. Gynacological complications (3).pptx
2. Gynacological complications (3).pptx2. Gynacological complications (3).pptx
2. Gynacological complications (3).pptx
 
Diabetes in ramadan
Diabetes in ramadanDiabetes in ramadan
Diabetes in ramadan
 
DRUG-STUDY-for-Case-presentation-finale.docx
DRUG-STUDY-for-Case-presentation-finale.docxDRUG-STUDY-for-Case-presentation-finale.docx
DRUG-STUDY-for-Case-presentation-finale.docx
 
Drug Used in Obstetric
Drug Used in ObstetricDrug Used in Obstetric
Drug Used in Obstetric
 

More from Monikashankar

CPD cephalo pelvi. .pptx
CPD cephalo pelvi.                 .pptxCPD cephalo pelvi.                 .pptx
CPD cephalo pelvi. .pptx
Monikashankar
 
Nursing Unit Management and. Leadership
Nursing Unit Management and.        LeadershipNursing Unit Management and.        Leadership
Nursing Unit Management and. Leadership
Monikashankar
 
FLUID AND ELETROLYTES BALANCE.pptx
FLUID AND ELETROLYTES BALANCE.pptxFLUID AND ELETROLYTES BALANCE.pptx
FLUID AND ELETROLYTES BALANCE.pptx
Monikashankar
 
preg complicating tumor anomalies.pptx
preg complicating tumor anomalies.pptxpreg complicating tumor anomalies.pptx
preg complicating tumor anomalies.pptx
Monikashankar
 
GENITAL TRACT INJURIES.pptx
GENITAL TRACT INJURIES.pptxGENITAL TRACT INJURIES.pptx
GENITAL TRACT INJURIES.pptx
Monikashankar
 
ANAEMIA IN PREGNANCY.ppt
ANAEMIA IN PREGNANCY.pptANAEMIA IN PREGNANCY.ppt
ANAEMIA IN PREGNANCY.ppt
Monikashankar
 
iugr-180818145504 (1).pdf
iugr-180818145504 (1).pdfiugr-180818145504 (1).pdf
iugr-180818145504 (1).pdf
Monikashankar
 
Hypertensive disorders of pregnancy.pptx
Hypertensive disorders of pregnancy.pptxHypertensive disorders of pregnancy.pptx
Hypertensive disorders of pregnancy.pptx
Monikashankar
 
OPERATIVE PROCEDURES.pptx
OPERATIVE PROCEDURES.pptxOPERATIVE PROCEDURES.pptx
OPERATIVE PROCEDURES.pptx
Monikashankar
 

More from Monikashankar (9)

CPD cephalo pelvi. .pptx
CPD cephalo pelvi.                 .pptxCPD cephalo pelvi.                 .pptx
CPD cephalo pelvi. .pptx
 
Nursing Unit Management and. Leadership
Nursing Unit Management and.        LeadershipNursing Unit Management and.        Leadership
Nursing Unit Management and. Leadership
 
FLUID AND ELETROLYTES BALANCE.pptx
FLUID AND ELETROLYTES BALANCE.pptxFLUID AND ELETROLYTES BALANCE.pptx
FLUID AND ELETROLYTES BALANCE.pptx
 
preg complicating tumor anomalies.pptx
preg complicating tumor anomalies.pptxpreg complicating tumor anomalies.pptx
preg complicating tumor anomalies.pptx
 
GENITAL TRACT INJURIES.pptx
GENITAL TRACT INJURIES.pptxGENITAL TRACT INJURIES.pptx
GENITAL TRACT INJURIES.pptx
 
ANAEMIA IN PREGNANCY.ppt
ANAEMIA IN PREGNANCY.pptANAEMIA IN PREGNANCY.ppt
ANAEMIA IN PREGNANCY.ppt
 
iugr-180818145504 (1).pdf
iugr-180818145504 (1).pdfiugr-180818145504 (1).pdf
iugr-180818145504 (1).pdf
 
Hypertensive disorders of pregnancy.pptx
Hypertensive disorders of pregnancy.pptxHypertensive disorders of pregnancy.pptx
Hypertensive disorders of pregnancy.pptx
 
OPERATIVE PROCEDURES.pptx
OPERATIVE PROCEDURES.pptxOPERATIVE PROCEDURES.pptx
OPERATIVE PROCEDURES.pptx
 

Recently uploaded

Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
fprxsqvnz5
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
The Lifesciences Magazine
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
VITASAuthor
 
Trauma Outpatient Center .
Trauma Outpatient Center                       .Trauma Outpatient Center                       .
Trauma Outpatient Center .
TraumaOutpatientCent
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
pchutichetpong
 
The Importance of Community Nursing Care.pdf
The Importance of Community Nursing Care.pdfThe Importance of Community Nursing Care.pdf
The Importance of Community Nursing Care.pdf
AD Healthcare
 
One Gene One Enzyme Theory.pptxvhvhfhfhfhf
One Gene One Enzyme Theory.pptxvhvhfhfhfhfOne Gene One Enzyme Theory.pptxvhvhfhfhfhf
One Gene One Enzyme Theory.pptxvhvhfhfhfhf
AbdulMunim54
 
Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.
Dinesh Chauhan
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
Naeemshahzad51
 
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
ranishasharma67
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
ssuser787e5c1
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Guillermo Rivera
 
PET CT beginners Guide covers some of the underrepresented topics in PET CT
PET CT  beginners Guide  covers some of the underrepresented topics  in PET CTPET CT  beginners Guide  covers some of the underrepresented topics  in PET CT
PET CT beginners Guide covers some of the underrepresented topics in PET CT
MiadAlsulami
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
Rajarambapu College of Pharmacy Kasegaon Dist Sangli
 
DRAFT Ventilator Rapid Reference version 2.4.pdf
DRAFT Ventilator Rapid Reference  version  2.4.pdfDRAFT Ventilator Rapid Reference  version  2.4.pdf
DRAFT Ventilator Rapid Reference version 2.4.pdf
Robert Cole
 
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsxChild Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Sankalpa Gunathilaka
 
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
salisonsalim1
 
karnapuran PPT made by Dr nishant very easy to understand how karanapuran is ...
karnapuran PPT made by Dr nishant very easy to understand how karanapuran is ...karnapuran PPT made by Dr nishant very easy to understand how karanapuran is ...
karnapuran PPT made by Dr nishant very easy to understand how karanapuran is ...
Nishant Taralkar
 
HEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptxHEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptx
priyabhojwani1200
 
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptxGLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
priyabhojwani1200
 

Recently uploaded (20)

Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
 
Trauma Outpatient Center .
Trauma Outpatient Center                       .Trauma Outpatient Center                       .
Trauma Outpatient Center .
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
 
The Importance of Community Nursing Care.pdf
The Importance of Community Nursing Care.pdfThe Importance of Community Nursing Care.pdf
The Importance of Community Nursing Care.pdf
 
One Gene One Enzyme Theory.pptxvhvhfhfhfhf
One Gene One Enzyme Theory.pptxvhvhfhfhfhfOne Gene One Enzyme Theory.pptxvhvhfhfhfhf
One Gene One Enzyme Theory.pptxvhvhfhfhfhf
 
Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
 
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
 
PET CT beginners Guide covers some of the underrepresented topics in PET CT
PET CT  beginners Guide  covers some of the underrepresented topics  in PET CTPET CT  beginners Guide  covers some of the underrepresented topics  in PET CT
PET CT beginners Guide covers some of the underrepresented topics in PET CT
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
 
DRAFT Ventilator Rapid Reference version 2.4.pdf
DRAFT Ventilator Rapid Reference  version  2.4.pdfDRAFT Ventilator Rapid Reference  version  2.4.pdf
DRAFT Ventilator Rapid Reference version 2.4.pdf
 
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsxChild Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
 
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
 
karnapuran PPT made by Dr nishant very easy to understand how karanapuran is ...
karnapuran PPT made by Dr nishant very easy to understand how karanapuran is ...karnapuran PPT made by Dr nishant very easy to understand how karanapuran is ...
karnapuran PPT made by Dr nishant very easy to understand how karanapuran is ...
 
HEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptxHEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptx
 
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptxGLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
 

Drugs used in pregnancy, labour and puerperium

  • 1. DRUGS USED IN PREGNANCY, LABOUR AND PUERPERIUM D.Padmapriya Tutor SAVEETHA CON
  • 2. INTRODUCTION • Drugs used in obstetrics have a huge impact on the outcome of both mother and baby. • Drugs used during first trimester can produce congenital malformation and the period of greatest risk is from the third to eleven weeks of pregnancy • During second and third trimester drugs can affect the growth and functional development of the fetus or they can have toxic effect on fetus tissues.
  • 3. DRUGS USED IN PREGNANCY List of drugs used in pregnancy are:- • Folic acid • Iron • Calcium • Anti -hypertensive drugs • Diuretics
  • 4. FOLIC ACID Preparation • Injection- 10ml vial (5mg/ml with 1.5% benzyl alchoal) • Tablet- 0.4mg , o.8mg , 1mg Action Stimulates normal erythropoiesis and nucleoprotein synthesis.
  • 5. Indications 1. Megaloblastic or macrocytic anemia during pregnancy to prevent fetal damage 2. Prevent fetal neural tube defect during pregnancy Contraindications 1. untreated vitamin B12 deficiency.
  • 6. Adverse effects 1. Abdominal cramps 2. Diarrhoea 3. Rash 4. Irritability 5. nausea or bloating Dosage and route of administration 0.4mg or 400mcg OD orally 0.4-0.8mg IM Or subcutaneously daily.
  • 7. Nursing consideration 1. Patient with H/O fetal neural tube defect in pregnancy should increase folic acid intake 1 month before and 3 months after conception. 2.Patient with intestinal malabsorption may need parentral administration.
  • 8. IRON (ferrous fumarate) Preparation Each 100mg provides 33mg of elemental iron. Tablet- 90mg,200mg,300mg,325mg,350mg Action Provides elemental iron, an essential component in the formation of haemoglobin.
  • 9. Indications 1. Iron deficiency 2. As a supplement during pregnancy Contraindications 1. Primary haemolytic anemia 2. Peptic ulcer disease 3. Ulcerative colitis 4. Repeated blood transfusions
  • 10. Adverse effects 1. Metallic taste 2. Temporary stained teeth 3. Nausea or vomiting 4. GI irritation 5. Black stools Dosage and routes of administration  30mg OD orally  Injection- 20mg elemental iron/ml in 5ml and 10ml single dose vial (iron sucrose )  Dose-15mg/kg body weight or max 1000mg in single Inj IM
  • 11. Nursing considerations 1. Advised patient to avoid taking tablet with milk or along with antacids. 2. Caution patient to crush tablet 3. Caution patient not to substitute one iron salt for another because amount of elemental iron may vary. 4. Advised patient to report for constipation or change in stool colour
  • 12. Calcium (calcium citrate) Preparation each tablet contains 211mg or 10.6meq of elemental calcium tablet- 250mg, 500mg Action Replaces calcium and maintain calcium level Indication supplement
  • 13. containdications 1. Cancer patients with bone metastasis 2. Hypercalcemia 3.Hypophosphatemia 4.Renal calculi Adverse effects 1. Headache 2. Irritability 3.Hypercalcemia 4.Chalky taste 5. Nausea or vomitings Dosage and route of administration
  • 14. Nursing considerations 1.Advise patient to take oral calcium 1 or 1.5 hours after meals if GI upset occurs 2. Monitor calcium level if the patient is having mild renal impairment. 3. Advise patient to report for any kind of abdominal pain, vomiting or nausea occurs.
  • 15. ANTIHYPERTENSIVE DRUGS Here are the choice of drugs given during pregnancy are:- 1. Alpha and Beta blockers- Labetalol hydrochloride 2. calcium channel blockers-Nifedipine 3.alpha blockers-Methyldopa 4.vasodilators-Hydralazine hydrochloride
  • 16. Anti hypertensive drugs contraindicated in pregnancy These drugs should be avoided because they may can cause poor fetal renal function, malformation or can cause IUGR 1.ACE inhibitors 2. Minoxidil 3. Sodium Nitoprusside 4. Diltiazem 5. Atenolol 6.Propranolol
  • 17. Labetalol Hydrochloride Preparation Injection-5mg/ml in 2oml vial Tablets- 100mg,2oomg ,300mg Action Reduced peripheral vascular resistance as a result of alpha and beta blockade.
  • 18. Indications 1.Hypertension 2.Hypertensive emergencies Contraindications 1.Hypersensitive to drug or its component. 2.Bronchial asthma 3.Hepatic or heart failure 4.Prolonged hypotension 5.Severe bradycardia
  • 19. Adverse effects 1. Dizziness 2. Fatigue 3. Nausea or vomiting 4. Headache 5. Vertigo Dosage and route of administration 50mg or 100mg tablet OD orally 20mg/20ml Inj IV bolus wait for 10min if no response then give 40mg slow bolus.
  • 20. Nursing considerations 1. Advised patient to remain in supine position for 3hrs after infusion. 2. Monitor BP frequently 3. In diabetic patient monitor glucose level closely. 4. Advised patient that dizziness can be minimized by rising slowly and avoiding sudden position change
  • 21. NIFEDIPINE Preparations Capsule-10mg,20mg Tablet-20mg,30mg,60mg,90mg Action Thought to inhibit calcium ion reflex across cardiac and smooth muscle cells, decreasing contractility and oxygen demand and also dilates arteries and arterioles.
  • 22. Indications 1. Hypertension 2. Classic chronic stable angina pectoris. Contraindications 1.Heart failure 2. Hypotension 3. Severe GI narrowing Adverse effects 1. Dizziness 2. Syncope 3. Heart failure 4. Muscle cramps 5. Peripheral edema
  • 23. Dosage and route of administrations 5-20mg OD orally. Nursing considerations 1. Monitor BP & HR regularly 2. Advise patient to avoid taking this drug with grapefruit juice. 3. Watch for symptoms for heart failure. 4. Advise patient if chest pain worsen immediately report to doctor.
  • 24. METHYLDOPA Preparations Tablet-250mg,500mg Inj-50mg/ml Action Inhibit the central vasomotor centre, decreasing sympathetic outflow to the heart, kidney and peripheral vasculature.
  • 25. Indications 1. Hypertension 2. Hypertensive crisis Contraindications 1. Hepatic disease or liver cirrhosis 2. Lactating mother Adverse effects 1. Decrease mental acuity 2. Sedation 3. Headache or depression 4. Bradycardia 5. Hepatic necrosis
  • 26. Dosage and routes of administration  250mg BD or TDS max 2g daily titrated by BP Nursing considerations 1. Monitor BP regularly. 2. Monitor patient coomb’s test result. 3. Report for involuntary movements. 4.Tell patient to check weight daily and notify if he gains 2 or more pounds in a week
  • 27. Hydralazine Hydrochloride Preparation  Inj-20mg/ml in 1ml vial  Tablet-10mg,25g,50mg,100mg Action Direct acting peripheral vasodilator that relexes arteriolar smooth muscle. Indications 1. Hypertension 2. Severe essential hypertension
  • 28. contraindications 1. Coronary artery disease 2. Rheumatic heart disease 3. Stroke 4. Severe renal impairment Adverse effects 1. Neutropenia 2. Leukopenia 3.Thrombocytopenia 4. Orthostatic hypotension
  • 29. Dosage and route of administration  25mg tablet BD and if necessary may increase to 50mg BD  5mg diluted in 10ml of NS slow IV at 15-20minutes interval. Nursing considerations 1. Monitor patient BP, pulse rate, body weight frequently. 2. Monitor patient for muscle and joint pain, fever or throat pain. 3. Advised patient to take drug after food to increase absorption
  • 30. DIURETICS Diuretics are used in the following conditions during pregnancy: 1. PIH with massive edema 2. Eclampsia with pulmonary edema 3. Severe anemia in pregnancy with heart failure 4. Prior to blood transfusion in severe anemia 5. As an adjunct to certain antihypertensive drugs.
  • 31. FUROSEMIDE (LASIX) Preparation  Inj-10mg/ml  Tablets-20mg,40mg,80mg,500mg Action Inhibits sodium and chloride reabsorption at proximal and distal tubules and loop of Henle. Indications 1. Acute pulmonary edema 2. Edema 3. Hypertension
  • 32. Contraindications 1. Anuria 2. Hepatic cirrhosis 3. Allergic to sulfonamides Adverse effects 1. Maternal: Weakness, fatigue, muscle cramps, hypokalemia 2. Fetal: May occur due to decreased leading to fetal compromise, hyponatremia. Dosage and routes of administration  40 mg tablet, daily following breakfast.  In acute conditions, the drug is administered parenterally in doses of 40-120 mg daily.
  • 33. Nursing considerations 1. Monitor weight, BP and pulse rate routinely for long term use. 2. Monitor patient I/O chart. 3. Watch the signs for hypokalemia such as muscle weakness and cramps. 4. Monitor uric acid if patient is having gout. 5. Advise the patient to take drug in the morning after food. 6. Advised patient to avoid direct sunlight to prevent photosensitivity reactions.
  • 34. TOCOLYTIC AGENTS These drugs can inhibit uterine contractions & used to prolonged the pregnancy. In women who develop premature uterine contractions, in addition to putting them to absolute bed rest & sedating, Tocolytic drugs are administered in an attempt to inhibit uterine contraction. Here are the drugs used are:- 1. Isoxsuprine Hydrochloride 2. Ritrodrine hydrochloride
  • 35. Isoxsuprine hydrochloride (Duvadilan) Preparation  Tablet -10mg  Inj-10mg/ml Action Acts directly on vascular smooth muscle, causes cardiac stimulation & uterine relaxation And thus causing relaxing the veins and arteries and making them wider to increase the blood flow to certain parts of the body. Indication 1. Prevent Preterm labour 2. Inhibit uterine contractions.
  • 36. Contraindications 1. Hypersensitivity 2. Postpartum Adverse effects 1. Hypotension 2. Tachycardia 3. Nausea or vomiting 4. Pulmonary edema 5. Cardiac arrhythmias 6. Hyperglycemia or hypokalemia
  • 37. Dosage & routes of administration  Initial: IV drip 100 mg in 5% dextrose @Rate0.2ug/minute.  To continue at least 2 hours after the contractions cease  Maintenance: IM 10mg 6 hourly for 24 hrs or tab 10mg 6- 8hrly. Nursing considerations 1. Assess patient BP, pulse during treatment 2.Take BP lying & standing as orthostatic hypotension is common 3. Monitor for Intensity & length of uterine contractions and FHS. 4. Advise patient to make position changes slowly as fainting may occur.
  • 38. Ritodrine hydrochloride (yutopar) Preparation  Inj-5ml amp-10mg/ml=50mg per amp.  Tablet-10mg Action Acts directly on vascular smooth muscle, causes cardiac stimulation & uterine relaxant. Indications Prevent preterm labour Contraindications 1. Hypersensitivity 2. Eclampsia 3. Hypertension 4. Dysrhythmias
  • 39. Adverse effects 1.Hyperglycemia 2. Headache 3. Restlessness or sweating 4. Chills and drowsiness 5. Nausea or vomiting 6. Altered maternal & fetal heart tone & palpitations. Dosage and routes of administration  Initial: IV drip 100 mg in 5% dextrose @ 0.1 mg/minute gradually increased by 0.05mg/min ,To continue for at least 2 hrs after contractions cease.  Maintenance -Tab 10mg 6-8 hourly PO 10 mg given half hour before termination of iv, then 10 mg q2 hr x 24 hrs, then 10-20 mg q4th, not to exceed 120 mg/day
  • 40. Nursing considerations 1. Assess Maternal & fetal heart tones during infusion and also Intensity & length of uterine contractions 2. Monitor Fluid intake to prevent fluid overload, discontinue if this occurs. 3. Administer only clear solutions after dilution 150 mg in 500 ml D5W or NS, give at 0.3 mg/ml By Using infusion pumps/monitor carefully 4. Positioning of patient in left lateral recumbent position to decrease hypotension & increase renal blood flow. 5. Advise patient to remain in bed during infusion.
  • 41. DRUGS USED IN LABOR Here are the drugs used in labor are:- 1.Oxytocics 2. Analgesics 3. Anticonvulsant 4. Anticoagulant
  • 42. OXYTOCICS Oxytocics are the drugs that have the power to excite contractions of the uterine muscles. Among a large number of drugs belonging to this group the ones that are important and extensively used are :- 1. Oxytocin 2. Ergot derivatives 3. Prostaglandins
  • 43. OXYTOCIN Oxytocin is an octapeptide synthesized in the hypothalamus and stored in the posterior pituitary. Preparations Synthetic oxytocin available for parenteral use includes:- • Syntocinon : 5units/ml in ampoules of 1 ml • Pitocin 10 units/ml in ampoule of 0.5 ml • Syntometrine : A combination of syntocinon on 5 units & ergometrine 0.5mg • Oxytocin nasal solution 40 unit/ml Actions Acts directly on myofibrils producing uterine contractions & stimulates milk ejection by the breasts
  • 44. Indications Pregnancy 1.To induce abortion, labour 2.To expedite expulsion of hydatidiform mole 3. For oxytocin challenge test 4.To stop bleeding following evacuation. Labour 1.To augment labour, in uterine inertia 2. to prevent & treat postpartum hemorrhage Postpartum 1.To initiate milk let-down in breast engorgement.
  • 45. Contraindications In late pregnancy 1. Grand multipara 2. Contracted pelvis 3. History of LSCS or hysterectomy 4. Malpresentation During labour 1. All contraindications mentioned in pregnancy 2. Obstructed labour 3. Incoordinate uterine action Anytime 1. Hypovolemic state, cardiac disease
  • 46. Adverse effects 1. Hypertonic uterine activity 2. Fetal distress & fetal death 3. Uterine rupture 4. Hypotension 5. Neonatal jaundice 6. Water retention & water intoxication Dosage & routes of administration  Controlled IV infusion ( 10 units of oxytocin in 1 L of RL/5% Dextrose in water)  Nasal spray for milk let- down
  • 47. Nursing considerations 1. Assess Patient I/O Ratio, Uterine contraction, BP, pulse & respiration 2. Administer By IV infusion After having crash cart available in the ward 3. Evaluate patient Length & duration of contractions and Notify physician of contractions lasting over one minute or absence of contractions.
  • 48. ERGOT DERIVATIVES Ergot alkaloids are either natural or semi synthetic Preparations Ergometrine- 0.25mg/ 0.5mg ampoules & 0.5-1mg tablets Methergine - 0.2 mg ampoules & 0.5-1mg tablets Syntometrine Ergometrine - 0.5 mg+ syntocinon 5.0 units ampoules.
  • 49. NOTE  Ergometrine & Methergine can be used parenterally or orally. As the drug produces titanic uterine contractions, it should only be used after delivery of the anterior shoulder or following delivery of baby.  It should not be used in induction of labor or abortion.  Syntometrine should always be administered IM Mode of Action Ergometrine acts directly on the myometrium. It stimulates uterine contractions & decreases bleeding.
  • 50. Indications Therapeutic 1.To stop the atonic uterine bleeding following delivery, abortion/ expulsion of hydatidiform mole Prophylactic 1. As a prophylaxis against excessive hemorrhage , it may be administered after the delivery of the anterior shoulder with crowing / following delivery of baby. Contraindications 1. Suspected plural pregnancy 2. Organic cardiac disease 3. Severe Pre-eclampsia & Eclampsia
  • 51. Adverse effects 1. Rise of BP due to vasoconstriction action 2. Prolonged use in puerperium may interfere by decrease concentration of prolactin & gangrene of toes due to vasoconstriction. Dosage and routes of administration  For active management of 3rd stage of labour - 0.2mg(iamp) to be given IM.  For control of atonic PPH -1amp slowly over 60 seconds, may be repeated after 2hrs.  For excessive lochia and subinvolution-1 Tablet(0.125mg)TDS for 3 days.
  • 52. Nursing considerations 1. Assess patient BP, pulse, respiration, signs of hemorrhage 2. Administer Orally/IM deep, have emergency cart readily available 3. Evaluate for decrease blood loss 4. Advised patient to report for increased blood loss, abdominal cramps, headache, sweating, nausea, vomiting/ dyspnea
  • 53. PROSTAGLANDINS Prostaglandins are synthesized from one of the essential fatty acids, archidonic acid, which is widely distributed throughout the body. In the female, these are identified in the menstrual fluid, endometrium, decidua & amniotic membrane.
  • 54. Preparations Tablet- 0.5mg 1. PG E2 – Prostin E2 ( Dinoprostone) Gel-0.5mg E2 in 2.5ml gel-comes in pre loaded syringe. 2. PG F2 alpha- Prostin F2 alpha ( Dinoprostodine) Inj- 125 and 250mcg 3. PGE1 – Misoprostol Tablet-100mcg,200mcg,600mcg Action Both PGE2 & PGF2 alpha have an oxytocic effect on the pregnant uterus. They also sensitize the myometrium to oxytocin. PGF2 alpha acts predominantly on the myometrium, while PGE2 acts mainly on the cervix.
  • 55. Indications 1. For induction of abortion during 2nd trimester & expulsion of hydatidiform mole 2. For induction of labor in IUD of fetus 3. In augmentation/ acceleration of labor 4.To stop bleeding from the open uterine sinuses as in refractory cases of atonic PPH 5. Cervical ripening Contraindications 1. Hypersensitivity 2. Uterine fibroids 3. Cervical stenosis 4. PID
  • 56. Side effects 1. Headache 2. Dizziness 3. Hypertension 4. leg cramps 5. Joint swelling Dosage & routes of administration  Tablets: containing o.5 mg prostin E2  Vaginal suppository: containing 20 mg PGE2 or 50 mg PGF2 alpha  Vaginal pessary: 3mg PGE2  Injectable ampoules/vials of prostinE2  1 mg/ml prostin F2 alpha  5mg/ml Misoprostol 50mg given 4 hourly by oral, vaginal/ rectal route for induction of labour
  • 57. Nursing considerations 1. Assess patient RR, rhythm & depth, vaginal discharge, itching/ irritation 2. Administer Antiemetic/ antidiarrheal preparations prior to giving this drug, high in vagina, after warming the suppository by running warm water over package 3. Evaluate patient for length & duration of contractions, notify physician of contractions lasting over 1 minute or absence of contractions, fever & chills 4. Advised patient to remain supine for 10-15 minutes after vaginal insertion.
  • 58. ANTICONVULSANTS MAGNESIUM SULPHATE Preparation  Inj- 1amp=2ml contains 1gm Mgso4.  Tablet-64mg Action Decreased acetylcholine in motor nerve terminals, which is responsible for anticonvulsant properties, thereby reduces neuromuscular irritability. It also decreases intracranial edema & helps in diuresis. Its peripheral vasodilatation effect improves the uterine blood supply. Has depressant action on the uterine muscles & CNS
  • 59. Indications 1. It is a valuable drug lowering seizure threshold in women with pregnancy- induced hypertension. 2. Used in preterm labor to decrease uterine activity. Contraindications 1. Heart block 2. Impaired renal function 3. Pregnant women actively progressing labor. Adverse effects • Maternal 1. Severe CNS depression 2. Evidence of muscular paresis • Fetal 1.Tachycardia 2. Hypoglycemia
  • 60. Dosage & routes of administration 1. For control of seizures, 20 ml of 20% solution IV slowly in 3-4 mins, to be followed immediately by 10ml of 50% solution IM & continued 4 hourly till 24 hours postpartum. Repeat injections are given only if knee jerks are present, urine output exceeds 100 ml in 4 hours & respiration are more than 10/ minute. The therapeutic level of serum magnesium is 4-7 mEq/L 2. 4gm IV slowly over 10 min, followed by 2 gm/hr and then 1gm/ hr in drip of 5% dextrose for tocolytic effect
  • 61. Nursing considerations 1. Assess patients Vital signs 15 min after IV dose, do not exceed 150 mg/min 2. Monitor magnesium level If using during labour, time of contractions, determine intensity 3. Urine output should remain 30 ml/hr or more if less notify physician 4. Examine patient Reflexes-knee jerk, patellar reflex. 5. Administer Only after calcium gluconate is available for treating magnesium toxicity
  • 62. 6. Using infusion pump/monitor carefully, IV at less than 150mg/min ,circulatory collapse may occur 7. Provide Seizure precautions: place client in single room with decreased stimuli, padded side rails 8. Positioning of client in left lateral recumbent position to decrease hypotension & increased renal blood flow 9. Evaluate patient Mental status , sensorium, memory , Respiratory status & Reflexes. 10. Discontinue infusion if respirations are below 12/min, reflexes severely hypotonic, urine output below 30ml/hr or in the event of mental confusion/ lethargy/ fetal distress.
  • 63. ANALGESICS valethamate bromide (epidosin) Cervical spasmolytic Preparation Inj-1amp-8mg/ml Action It is both central and peripheral antimuscarininc agent, which is a competitive inhibitor of acetylcholine at the muscarinic receptor. Indication 1. Cervical dilatation in the first stage of labor. 2. Symptomatic relief of GI tract and ureteric colic.
  • 64. Contraindications 1. Paralytic ileus 2. Myasthemia Gravis 3. Hypertension 4. Ulcerative colitis 5. Closed angle glaucoma 6. CVS disorders Adverse effects 1. Dryness of mouth 2. Thirst 3. Dilatation of pupil 4. Palpitations 5. Giddiness
  • 65. Dosage and routes of administration Inj-8mg deep IM. It may be repeated after 4 hours if necessary. Nursing considerations 1. Advise patient to report for any blurred vision, giddiness ,dry mouth immediately. 2. Advise patient to get up from the bed carefully and slowly.
  • 66. Tramadol hydrochloride Preparation  Inj-1amp=50mg  Tablet-50mg,100mg,200mg Action Bind to opioid receptor and inhibit reuptake of norepinephrine and serotonin Indications 1. Moderate to moderately severe pain 2. Safe given during labor as it does not cause depression to fetal respiratory centre and hence safe for baby.
  • 67. Contraindications 1. Breast feeding mothers 2. Hypersensitiviy 3. Hepatic impairment 4. Increased ICP Adverse effects 1. Dizziness 2. Headache 3. Malaise 4. Hypertonia 5. Nausea or vomiting
  • 68. Dosage and routes of administration 50 to 100mg IM 6hrly or as required. Nursing considerations 1. Monitor patient CV and respiratory status. 2. Monitor patient at risk for seizure. 3. Monitor patient bowel and bladder function.
  • 69. COAGULANT Vitamin K(phytonadione At birth, the newborn does not have bacteria in the colon that necessary for synthesizing fat soluble vitamin k. Therefore newborns have decreased level of Prothrombin during the first 5 to 8 days of life. Preparation INJ- 2ml vial=2mg/ml
  • 70. Action It promotes the hepatic formation of the clotting factors II,VII,IX and X. Indications 1. It is used to treat or prevent certain bleeding problems. 2. It helps liver to produce blood clotting factors Contraindications Hypersensitivity Adverse effects 1. Pain and edema may occur at injection site. 2. Allergic reaction such as rash and urticarial may occur. 3. Hyperbilirubinemia
  • 71. Dosage and routes of administration 0.5mg IM within 1 hour of birth. Nursing considerations 1. Document the giving of the medication to newborn to prevent an accidental doubling. 2. Observe for bleeding usually occurs on 2nd and 3rd day. 3. Observe for jaundice 4. Observe for local inflammation.
  • 72. DRUGS GIVEN DURING PUERPERIUM Here are the drugs given during puperium are:- 1.Iron 2.Folic acid 3.Calcium 4.Acetaminophen(paracetamol) 5.Lactation suppressant (in case of stillbirth, neonatal death, breast abscess or severe psychiatric illness.
  • 73. Acetaminophen (paracetamol) Preparation  Tablet-80mg,160mg,500mg  Suppository-80mg,120mg  Oral solution-16m/ml,80mg/ml Action Produce analgesia by inhibiting prostaglandins and other substances that sensitizes pain receptors. Indications 1. Mild to moderate pain 2. Fever
  • 74. Contraindications 1. Liver disease 2. Hypersensitivity Adverse effects 1. Neutropenia 2. Hemolytic anemia 3. Hypoglycemia 4. Urticaria
  • 75. Dosage and routes of administration 500mg tablet thrice a day for 5 days Nursing considerations 1. Advise the patient to not to exceed the prescribed dose. 2. Advise the patient hat drug is only for short term use and avoid taking OTC drugs without prescription. 3. Advise patient to take tablet after meal to prevent GI symptoms.
  • 76. Lactation suppressants (Bromocriptine mesylate) Preparation  Tablet-0.8mg,2.5mg Action It blocks the release of a prolactin from the pituitary gland. Indications 1. Suppression of lactation 2. Pregnancy with prolactinoma 3. Infertility 4.Amenorrhoea
  • 77. Adverse effects 1. Dizziness or lightheadedness especially when getting up from lying position. 2. Confusion 3. Hallucinations 4. Hypertension 5. Seizures 6. Myocardial infarction Dosage and routes of administration  2.5mg tablet orally once in a day.
  • 78. Nursing considerations 1. Monitor patient for adverse reactions 2. Drug may lead to early post partum conception .after menses resumes, test for pregnancy every 4 weeks or as soon as period is missed 3. Assess orthostatic vital signs before initiation of the therapy. 4. Instruct the patient to take drug with meal.
  • 79. EFFECTS OF MATERNAL MEDICATIONS ON FETUS & BREAST FEEDING INFANTS 1. During early embryogenesis, the drugs taken by the mother reach the conceptus through the tubal/ uterine secretions by diffusion. 2. The harmful effect on the blastocyst is usually death, in case of survival there is chance of congenital anomalies 3. From 2nd-12th week (period of organogenesis) drugs can cause serious damages 4. Gross congenital malformations & even death of the fetus may result, depending on route, length of time & dose of exposure
  • 80. 5. From 2nd trimester transfer of drugs takes place through the utero-placental circulation due to lowered serum albumin concentration which results from haemodilution 6. As the albumin binding capacity of the drugs is decreased more free drug is available for placental transfer 7.The metabolism of the drug may be hampered by the increase in plasma steroids, increased utero-placental blood flow, increased placental surface area & decreased thickness of placental membrane are the additional cause for increased drug transfer 8. Fetotoxic/ teratogenic drugs are prescribed only when the benefits out weigh the potential risks. Prior councelling is mandatory & minimum therapeutic dosage is used for shortest possible duration
  • 81. Maternal medications with established teratogenic properties & their effects 1.Cytotoxic drugs: multiple fetal malformations & abortion 2.Androgenic steroids, hydroxy progesterone: masculinization of the female offspring 3.Lithium: increased congenital malformations when used in the 1st trimester, neonatal goitre, hypotonia & cynosis 4.Diethyl stillbestrol: vaginal stenosis, cervical hoods & uterine hypoplasia in female fetuses.
  • 82. Maternal drug intake & breastfeeding Maternal drug intake of nursing mothers have adverse effects on lactation & also on the baby as it may be present on the breast milk • Transfer of drugs through breast milk depends on the following factors: • Chemical properties • Molecular weight • Degree of protein binding • Ionic dissociation • Lipid solubility • Tissue pH • Drug concentration • Exposure time
  • 83. Drugs identified as having effects on lactation & the neonates are listed below: • Bromides: rash, drowsiness, poor feeding • Iodides: neonatal hypothyroidism • Chloramphenicol: bone marrow toxicity • Oral pill: suppression of lactation • Bromocriptine: suppression of lactation • Ergot: suppression of lactation • Metronidazol: anorexia, blood dyscrasias, weakness, neurotoxic disorders
  • 84. • Anticoagulants: hemorrhagic tendency • Isoniazid: anti-DNA activity & hepatotoxicity • Antithyroid drugs & radioactive iodine: hypothyroidism & goiter • Diazepam, opiates, phenobarbitone: sedation effect with poor sucking reflex.
  • 85. CONCLUSION • No drug should be administered to a woman during pregnancy, labor and birth, unless the woman is fully informed of the known risks and the relevant areas of uncertainty regarding the effects of the drug on the physiologic and neurologic development of the woman or her baby • The drugs that are used daily in obstetric can have a huge impact on the outcome of both mother and child. • Therefore, obstetric providers need to have a very clear understanding of the mechanism of action, doses and side-effects of the most commonly used drugs.
  • 86. BIBLIOGRAPHY • 1. Annamma Jacob “ A Comprehensive Textbook of Midwifery & Gynecological Nursing” 3rd edition. Jaypee Brothers Medical Publishers (P) Ltd page no. 604-619 • 2. D.C.Dutta’s “Textbooks of Obstetrics” 7th edition. New Central Book Agency (P) Ltd page no.666. • 3. A.K Debdas “Drug handbook in Obstetrics”,3rd edition.Jaypee brothers and medical publishers private limited, New Delhi. • 4. wolter Kluwer “Drug handbook”32 edition.lippincot William &Wilkinson publisher ,London. • 5.www.medicine.tcd.ie/pharmacology_therapeutics/....Obs&G yn.pdf • 6.www.elmmb.nhs.uk/formularies/joint-medicines-